Garry E. Menzel - 03 Jun 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role: Director
Signature: /s/ Jonathan Allan, Attorney-in-Fact
Issuer symbol: STOK
Transactions as of: 03 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2025, 20:35:43 UTC
Previous filing: 01 Jul 2024
Next filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Menzel Garry E	Director	C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD	/s/ Jonathan Allan, Attorney-in-Fact	04 Jun 2025	0001556064

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STOK	Director Stock Option (Right to Buy)	Award	$0	+29,747		$0.000000	29,747	03 Jun 2025	Common Stock	29,747	$10.90	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shall vest in full on the earlier of: (i) June 3, 2026 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date.